N-Oxide polymer–cupric ion nanogels potentiate disulfiram for cancer therapy

Yin Zhong, Rui Sun, Yu Geng, Quan Zhou, Ying Piao, Tao Xie, Ruhong Zhou and Youqing Shen

Biomater. Sci., 2020, 8, 1726
DOI: 10.1039/C9BM01841G

Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment

Bin Tu, Yang He, Binfan Chen, Yonghui Wang, Yanrong Gao, Mingjie Shi, Tuanbing Liu, Akmal M. Asrorov and Yongzhuo Huang

Biomater. Sci., 2020, 8, 7166
DOI: 10.1039/D0BM01516D

BSA–MnO2–SAL multifunctional nanoparticle-mediated M1 macrophages polarization for glioblastoma therapy

Fuming Liang, Ling Zhu, Chen Wang, Yanlian Yang and Zhaohui He

RSC Adv., 2021, 11, 35331
DOI: 10.1039/D1RA06705B

Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment

Attilio Marino, Alice Camponovo, Andrea Degl'Innocenti, Martina Bartolucci, Christos Tapeinos, Chiara Martinelli, Daniele De Pasquale, Francesca Santoro, Valentina Mollo, Satoshi Arai, Madoka Suzuki, Yoshie Harada, Andrea Petretto and Gianni Ciofani

Nanoscale, 2019, 11, 21227
DOI: 10.1039/C9NR07976A

Dual targeting nanoparticles for epilepsy therapy

Qinghong Hou, Lulu Wang, Feng Xiao, Le Wang, Xiaoyan Liu, Lina Zhu, Yi Lu, Wenfu Zheng and Xingyu Jiang

Chem. Sci., 2022, 13, 12913
DOI: 10.1039/D2SC03298H

Comprehensive review on glioblastoma: nanotechnology, immunotherapy and combined therapeutic approaches

Ashish Dhiman, Yagni Shah, Dhwani Rana and Kalpna Garkhal

RSC Pharm., 2025, 2, 207
DOI: 10.1039/D4PM00263F

Imaging strategies for monitoring the immune response

Xiaohan Liu, Limeng Pan, Kaiye Wang, Wei Pan, Na Li and Bo Tang

Chem. Sci., 2022, 13, 12957
DOI: 10.1039/D2SC03446H

A dithiocarbamate-based H2O2-responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy

Qingqing Pan, Boya Zhang, Xinyu Peng, Shiyu Wan, Kui Luo, Wenxia Gao, Yuji Pu and Bin He

Chem. Commun., 2019, 55, 13896
DOI: 10.1039/C9CC05438C

Angiopep-2 conjugated nanoparticles loaded with doxorubicin for the treatment of primary central nervous system lymphoma

Xiao-Xiao Shi, Wei-Min Miao, Di-Wen Pang, Jia-Si Wu, Qi-Song Tong, Jia-Xian Li, Jia-Qi Luo, Wen-Yu Li, Jin-Zhi Du and Jun Wang

Biomater. Sci., 2020, 8, 1290
DOI: 10.1039/C9BM01750J

Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core–shell nanoparticles for enhanced tumor-localized chemoimmunotherapy

Tianqi Wang, Jing Zhang, Teng Hou, Xiaolan Yin and Na Zhang

Nanoscale, 2019, 11, 13934
DOI: 10.1039/C9NR03374B

Recent development in biodegradable nanovehicle delivery system-assisted immunotherapy

Zhenfu Wen, Fengyu Liu, Qing Chen, Yongqian Xu, Hongjuan Li and Shiguo Sun

Biomater. Sci., 2019, 7, 4414
DOI: 10.1039/C9BM00961B

Anti-glioma trichobamide A with an unprecedented tetrahydro-5H-furo[2,3-b]pyrrol-5-one functionality from ascidian-derived fungus Trichobotrys effuse 4729

Senhua Chen, Hongjie Shen, Panpan Zhang, Hongwei Cheng, Xingliang Dai and Lan Liu

Chem. Commun., 2019, 55, 1438
DOI: 10.1039/C8CC08970A

Small functionalized iron oxide nanoparticles for dual brain magnetic resonance imaging and fluorescence imaging

Ruixue Wei, Yang Liu, Jinhao Gao, V. Wee Yong and Mengzhou Xue

RSC Adv., 2021, 11, 12867
DOI: 10.1039/D0RA10392F

Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer

Yonghui Wang, Binfan Chen, Zhidi He, Bin Tu, Pengfei Zhao, Huiyuan Wang, Akmal Asrorov, Bahtiyor Muhitdinov, Jizong Jiang and Yongzhuo Huang

Nanoscale, 2022, 14, 2304
DOI: 10.1039/D1NR06518A

New insight into brain disease therapy: nanomedicines-crossing blood–brain barrier and extracellular space for drug delivery

Ziqi Gu, Haishu Chen, Han Zhao, Wanting Yang, Yilan Song, Xiang Li, Yang Wang, Dan Du, Haikang Liao, Wenhao Pan, Xi Li, Yajuan Gao, Hongbin Han and Zhiqian Tong

Expert Opinion on Drug Delivery, 2022, 19, 1618
DOI: 10.1080/17425247.2022.2139369

Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment

Peijie Wu, Wei Gao, Miao Su, Edouard C. Nice, Wenhui Zhang, Jie Lin and Na Xie

Front. Cell Dev. Biol., 2021, 9
DOI: 10.3389/fcell.2021.641469

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

Suhaila O. Alhaj-Suliman, Emad I. Wafa and Aliasger K. Salem

Advanced Drug Delivery Reviews, 2022, 189, 114482
DOI: 10.1016/j.addr.2022.114482

Targeted nanomedicine for reprogramming the tumor innate immune system: From bench to bedside

Kunal Pednekar, Julia Minnee, I. Jolanda M. de Vries and Jai Prakash

European Journal of Pharmaceutics and Biopharmaceutics, 2024, 204, 114510
DOI: 10.1016/j.ejpb.2024.114510

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

Zhi-Guo Lu, Jie Shen, Jun Yang, Jing-Wen Wang, Rui-Chen Zhao, Tian-Lu Zhang, Jing Guo and Xin Zhang

Sig Transduct Target Ther, 2023, 8
DOI: 10.1038/s41392-022-01298-z

Doxorubicin Delivered via ApoE-Directed Reduction-Sensitive Polymersomes Potently Inhibit Orthotopic Human Glioblastoma Xenografts in Nude Mice

Jia Ouyang, Yu Jiang, Chao Deng, Zhiyuan Zhong and Qing Lan

IJN, 2021, Volume 16, 4105
DOI: 10.2147/IJN.S314895

Disulfiram: A novel repurposed drug for cancer therapy

Min Zeng, Baibei Wu, Wenjie Wei, Zihan Jiang, Peiqiang Li, Yuanting Quan and Xiaobo Hu

Chinese Medical Journal, 2024, 137, 1389
DOI: 10.1097/CM9.0000000000002909

Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death

Xuejia Kang, Yuxin Cai, Qi Wang, Chuanyu Wang, Wu Chen, Wen Yang, Amol Suryawanshi, Gang Zhou, Pengyu Chen and Feng Li

International Journal of Pharmaceutics, 2021, 607, 120972
DOI: 10.1016/j.ijpharm.2021.120972

A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy

Weiwei Mu, Qihui Chu, Yongjun Liu and Na Zhang

Nano-Micro Lett., 2020, 12
DOI: 10.1007/s40820-020-00482-6

Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms

Jixuan Zheng, Jinting Jiang, Yicheng Pu, Tingrui Xu, Jiantong Sun, Qiang Zhang, Ling He and Xiao Liang

Front. Bioeng. Biotechnol., 2023, 11
DOI: 10.3389/fbioe.2023.1248421

Role of cellular, molecular and tumor microenvironment in hepatocellular carcinoma: Possible targets and future directions in the regorafenib era

Sarun Juengpanich, Win Topatana, Chen Lu, Daniel Staiculescu, Shijie Li, Jiasheng Cao, Jiacheng Lin, Jiahao Hu, Mingyu Chen, Jiang Chen and Xiujun Cai

Intl Journal of Cancer, 2020, 147, 1778
DOI: 10.1002/ijc.32970

A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells

Yuki Mizuta, Hitoshi Maeda, Yu Ishima, Yuki Minayoshi, Shota Ichimizu, Ryo Kinoshita, Issei Fujita, Takuma Kai, Kenshiro Hirata, Teruya Nakamura, Junji Saruwatari, Hidetoshi Arima, Hiroshi Watanabe, Masaki Otagiri and Toru Maruyama

Adv Funct Materials, 2021, 31
DOI: 10.1002/adfm.202104136

Tumor microenvironment: Interactions and therapy

Masoud Najafi, Nasser Hashemi Goradel, Bagher Farhood, Eniseh Salehi, Somaye Solhjoo, Heidar Toolee, Ebrahim Kharazinejad and Keywan Mortezaee

Journal Cellular Physiology, 2019, 234, 5700
DOI: 10.1002/jcp.27425

Immunomodulatory effects of regorafenib: Enhancing the efficacy of anti-PD-1/PD-L1 therapy

Junjie Liu, Haisu Tao, Tong Yuan, Jiang Li, Jian Li, Huifang Liang, Zhiyong Huang and Erlei Zhang

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.992611

Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis

Abhalaxmi Singh, Sreeparna Chakraborty, Sing Wan Wong, Nicole A. Hefner, Andrew Stuart, Abdul S. Qadir, Amitabha Mukhopadhyay, Kurt Bachmaier, Jae-Won Shin, Jalees Rehman and Asrar B. Malik

Proc. Natl. Acad. Sci. U.S.A., 2022, 119
DOI: 10.1073/pnas.2121098119

Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?

Daniel Ruiz-Molina, Xiaoman Mao, Paula Alfonso-Triguero, Julia Lorenzo, Jordi Bruna, Victor J. Yuste, Ana Paula Candiota and Fernando Novio

Cancers, 2022, 14, 4960
DOI: 10.3390/cancers14194960

Disulfiram: A Food and Drug Administration-approved multifunctional role in synergistically drug delivery systems for tumor treatment

Lushuang Xu, Yue Sun, Yue Li, Junli Sun, Yong Guo, Qiying Shen, Qiaolin Wei and Jia-Wei Shen

International Journal of Pharmaceutics, 2022, 626, 122130
DOI: 10.1016/j.ijpharm.2022.122130

Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape

Zide Wang, Hanlin Zhong, Xiaohong Liang and Shilei Ni

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.1024921

Advancement of cancer immunotherapy using nanoparticles-based nanomedicine

Vemana Gowd, Anas Ahmad, Mohammad Tarique, Mohd Suhail, Torki A. Zughaibi, Shams Tabrez and Rehan Khan

Seminars in Cancer Biology, 2022, 86, 624
DOI: 10.1016/j.semcancer.2022.03.026

Mannose-coated superparamagnetic iron oxide nanozyme for preventing postoperative cognitive dysfunction

Qianyun Zhu, Yuting Huang, Xiaoling Zhu, Lijun Peng, Huan Wang, Shan Gao, Zhilai Yang, Jiqian Zhang and Xuesheng Liu

Materials Today Bio, 2023, 19, 100568
DOI: 10.1016/j.mtbio.2023.100568

Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances

Tingrui Zhang, Zongguang Tai, Fengze Miao, Xinyue Zhang, Jiadong Li, Quangang Zhu, Hua Wei and Zhongjian Chen

Journal of Controlled Release, 2024, 368, 372
DOI: 10.1016/j.jconrel.2024.02.033

Sub-micronization of disulfiram and disulfiram-copper complexes by Rapid expansion of supercritical solution toward augmented anticancer effect

Han-Xiao Tang, Yuan-Yuan Cai, Chen-Guang Liu, Jian-Ting Zhang, Ranjith Kumar Kankala, Shi-Bin Wang and Ai-Zheng Chen

Journal of CO2 Utilization, 2020, 39, 101187
DOI: 10.1016/j.jcou.2020.101187

Bidirectional Regulation in the Tumour Microenvironment: The Interaction Between Tumour‐Associated Macrophages and T Cells Reshapes the Paradigm of Cancer Immunotherapy

Yuting Li and Lufang Wang

Immunology, 2026, 178, 1
DOI: 10.1111/imm.70103

Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma

Amy Xiao and Oleg E. Akilov

Cells, 2022, 11, 3591
DOI: 10.3390/cells11223591

Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy

Anne McMahon, Wu Chen and Feng Li

Journal of Controlled Release, 2020, 319, 352
DOI: 10.1016/j.jconrel.2020.01.001

Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors

Li Zhang, Yue Liu, Haiyan Huang, Hui Xie, Baozhu Zhang, Wujiong Xia and Bing Guo

Advanced Drug Delivery Reviews, 2022, 190, 114536
DOI: 10.1016/j.addr.2022.114536

Teaching new tricks to old dogs: A review of drug repositioning of disulfiram for cancer nanomedicine

Pengfei Zhao, Xueping Tang and Yongzhuo Huang

VIEW, 2021, 2
DOI: 10.1002/VIW.20200127

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy

Bin Tu, Meng Zhang, Tuanbing Liu and Yongzhuo Huang

Front. Cell Dev. Biol., 2020, 8
DOI: 10.3389/fcell.2020.00400

Frontiers in the treatment of glioblastoma: Past, present and emerging

Taskeen Iqbal Janjua, Prarthana Rewatkar, Aria Ahmed-Cox, Iqira Saeed, Friederike M. Mansfeld, Ritu Kulshreshtha, Tushar Kumeria, David S. Ziegler, Maria Kavallaris, Roberta Mazzieri and Amirali Popat

Advanced Drug Delivery Reviews, 2021, 171, 108
DOI: 10.1016/j.addr.2021.01.012

Nanomaterials as Microglia Modulators in the Treatment of Central Nervous System Disorders

Matteo Battaglini, Attilio Marino, Margherita Montorsi, Alessio Carmignani, Maria Cristina Ceccarelli and Gianni Ciofani

Adv Healthcare Materials, 2024, 13
DOI: 10.1002/adhm.202304180

Immunotherapy for Malignant Glioma: Current Status and Future Directions

Hongxiang Wang, Tao Xu, Qilin Huang, Weilin Jin and Juxiang Chen

Trends in Pharmacological Sciences, 2020, 41, 123
DOI: 10.1016/j.tips.2019.12.003

Targeting aldehyde dehydrogenase enzymes in combination with chemotherapy and immunotherapy: An approach to tackle resistance in cancer cells

Salma A. Al-Shamma, Dana M. Zaher, Fatema Hersi, Nour N. Abu Jayab and Hany A. Omar

Life Sciences, 2023, 320, 121541
DOI: 10.1016/j.lfs.2023.121541

CSF1R inhibitor C19 for glioma immunotherapy enabled by brain-targeting liposomal delivery

Wen-qin Song, Yue-qian Wu, Quan-feng Zhu, Xing-ping Xia, Rui Wang, Lu Yang, Li-hong Hu, Jun-wei Wang, Yong-zhuo Huang and Hui-yuan Wang

Acta Pharmacol Sin, 2026
DOI: 10.1038/s41401-025-01727-z

Two-Way Cruise Nanosatellite Promotes Metastasis Inhibition by Immunochemotherapy

Bin Du, Qinghui Wang, Ying Yang, Qian Du, Ying Liu, Wanying Zhu, Tianguo Xu, Guopeng Shen, Hanchun Yao and Lei Wang

Biomacromolecules, 2019, 20, 2873
DOI: 10.1021/acs.biomac.9b00788

Immunosuppressive triangle depletion through the combination punches strategy for enhanced immunotherapy

Qianhua Feng, Huifang Xiao, Cuixia Zheng, Xueli Zhang, Zeying Wang and Lei Wang

Applied Materials Today, 2022, 26, 101315
DOI: 10.1016/j.apmt.2021.101315

Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy

Xiaojie Lin, Yan Fang, Xuechao Jin, Mingming Zhang and Kai Shi

ACS Appl. Bio Mater., 2021, 4, 5871
DOI: 10.1021/acsabm.1c00461

Brain-targeting biomimetic nanoparticles for codelivery of celastrol and LY2157299 for reversing glioma immunosuppression

Siqi Zhu, Feifei Sun, Pengfei Zhao, Gang Liang, Xiaoyi Sun, Linghui Zeng and Yongzhuo Huang

International Journal of Pharmaceutics, 2022, 619, 121709
DOI: 10.1016/j.ijpharm.2022.121709

Copper in cancer: From pathogenesis to therapy

Defeng Guan, Lihui Zhao, Xin Shi, Xiaoling Ma and Zhou Chen

Biomedicine & Pharmacotherapy, 2023, 163, 114791
DOI: 10.1016/j.biopha.2023.114791

Chitosan/alginate polyelectrolyte complex hydrogels by additive manufacturing for in vitro 3D ovarian cancer modeling

Simona Braccini, Gianni Pecorini, Serena Biagini, Chiara Tacchini, Antonella Battisti and Dario Puppi

International Journal of Biological Macromolecules, 2025, 296, 139795
DOI: 10.1016/j.ijbiomac.2025.139795

Nanoparticle‐Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions

Jianping Liu, Run Zhang and Zhi Ping Xu

Small, 2019, 15
DOI: 10.1002/smll.201900262

Nonviral vector system for cancer immunogene therapy

Wen Nie, Jing Chen, Bilan Wang and Xiang Gao

MedComm – Biomaterials and Applications, 2022, 1
DOI: 10.1002/mba2.10

Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme

Xin Yuan Lim, Sharah Mae Capinpin, Nagarjun Bolem, Aaron Song Chuan Foo, Wai‐Cheong George Yip, Alan Prem Kumar and Daniel Boon Loong Teh

Bioengineering & Transla Med, 2023, 8
DOI: 10.1002/btm2.10483

Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer

Shogo Takei, Yosuke Tanaka, Yi-Tzu Lin, Shohei Koyama, Shota Fukuoka, Hiroki Hara, Yoshiaki Nakamura, Yasutoshi Kuboki, Daisuke Kotani, Takashi Kojima, Hideaki Bando, Saori Mishima, Toshihide Ueno, Shinya Kojima, Masashi Wakabayashi, Naoya Sakamoto, Motohiro Kojima, Takeshi Kuwata, Takayuki Yoshino, Hiroyoshi Nishikawa, Hiroyuki Mano, Itaru Endo, Kohei Shitara and Akihito Kawazoe

J Immunother Cancer, 2024, 12, e008210
DOI: 10.1136/jitc-2023-008210

Nanoparticle-Based Therapeutics to Overcome Obstacles in the Tumor Microenvironment of Hepatocellular Carcinoma

Yuanfei Lu, Na Feng, Yongzhong Du and Risheng Yu

Nanomaterials, 2022, 12, 2832
DOI: 10.3390/nano12162832

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment

Muyue Yang, Jipeng Li, Ping Gu and Xianqun Fan

Bioactive Materials, 2021, 6, 1973
DOI: 10.1016/j.bioactmat.2020.12.010

The combination of disulfiram and copper for cancer treatment

Hong Li, Jingyu Wang, Chunfu Wu, Lihui Wang, Zhe-Sheng Chen and Wei Cui

Drug Discovery Today, 2020, 25, 1099
DOI: 10.1016/j.drudis.2020.04.003

Roles of Albumin‐Binding Proteins in Cancer Progression and Biomimetic Targeted Drug Delivery

Pengfei Zhao, Yonghui Wang, Aihua Wu, Yuefeng Rao and Yongzhuo Huang

ChemBioChem, 2018, 19, 1796
DOI: 10.1002/cbic.201800201

Herbal extracts in Novel Drug Delivery System: A Magical Combo: A Brief Review

Sheetal Sharma, Jigar Vyas and Umesh Upadhyay

RJPDFT, 2022, 150
DOI: 10.52711/0975-4377.2022.00024

Circular RNA 0001789 sponges miR-140-3p and regulates PAK2 to promote the progression of gastric cancer

Jun You, Yinan Chen, Donghan Chen, Yongwen Li, Tinghao Wang, Jingtao Zhu, Qingqi Hong and Qiyuan Li

J Transl Med, 2023, 21
DOI: 10.1186/s12967-022-03853-2

Emerging roles of ECM remodeling processes in cancer

Vishnu Mohan, Alakesh Das and Irit Sagi

Seminars in Cancer Biology, 2020, 62, 192
DOI: 10.1016/j.semcancer.2019.09.004

Co-delivery of paclitaxel and regorafenib by F127/TPGS mixed micelles for triple negative breast cancer treatment

Sepideh Nezhadi, Parisa Norouzi, Azadeh Rasouli, Hamid Akbari Javar, Seyed Nasser Ostad and Farid Dorkoosh

Journal of Drug Delivery Science and Technology, 2023, 86, 104673
DOI: 10.1016/j.jddst.2023.104673

Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery

Binfan Chen, Ang Gao, Bin Tu, Yonghui Wang, Xiaolu Yu, Yingshu Wang, Yanfeng Xiu, Bing Wang, Yakun Wan and Yongzhuo Huang

Biomaterials, 2020, 255, 120187
DOI: 10.1016/j.biomaterials.2020.120187

Extracellular matrix (ECM) stiffness and degradation as cancer drivers

Masoud Najafi, Bagher Farhood and Keywan Mortezaee

J of Cellular Biochemistry, 2019, 120, 2782
DOI: 10.1002/jcb.27681

Origin, activation, and targeted therapy of glioma-associated macrophages

Can Xu, Menglin Xiao, Xiang Li, Lei Xin, Jia Song, Qi Zhan, Changsheng Wang, Qisong Zhang, Xiaoye Yuan, Yanli Tan and Chuan Fang

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.974996

Exosomal miR-145-5p impairs neoadjuvant chemotherapy by suppressing TFRC-mediated macrophage iron uptake and driving M2 polarization in esophageal cancer

Jianfeng Xu, Deng Lei, Peng Xu, Yuqi Wang, Zhupeng Li, Jiacheng Wu, Weizhong Feng and Junqing Zhou

Human Cell, 2025, 39
DOI: 10.1007/s13577-025-01337-1

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents

Vinodh Kannappan, Misha Ali, Benjamin Small, Gowtham Rajendran, Salena Elzhenni, Hamza Taj, Weiguang Wang and Q. Ping Dou

Front. Mol. Biosci., 2021, 8
DOI: 10.3389/fmolb.2021.741316

Macrophage polarity in cancer: A review

Masoud Najafi, Nasser Hashemi Goradel, Bagher Farhood, Eniseh Salehi, Maryam Shabani Nashtaei, Neda Khanlarkhani, Zahra Khezri, Jamal Majidpoor, Morteza Abouzaripour, Mohsen Habibi, Iraj Ragerdi Kashani and Keywan Mortezaee

J of Cellular Biochemistry, 2019, 120, 2756
DOI: 10.1002/jcb.27646

Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced in vivo antitumor cancer therapy in nursing care

Zhe Zhou

Drug Delivery, 2020, 27, 1319
DOI: 10.1080/10717544.2020.1815897

Nanomaterial-Enabled Modulation of Tumor-Associated Macrophages and Dendritic Cells to Enhance Cancer Immunotherapy

Anbu Mozhi Thamizhchelvan, Kory Wells, Jacob Pham, Ashan Galhena and Woojin Kim

Nanomaterials, 2026, 16, 172
DOI: 10.3390/nano16030172

Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives

Rafieh Bagherifar, Seyed Hossein Kiaie, Zahra Hatami, Armin Ahmadi, Abdolvahid Sadeghnejad, Behzad Baradaran, Reza Jafari and Yousef Javadzadeh

J Nanobiotechnol, 2021, 19
DOI: 10.1186/s12951-021-00861-0

A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment

Soumyadeep Chattopadhyay, Rudradeep Hazra, Arijit Mallick, Sakuntala Gayen and Souvik Roy

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024, 1879, 189110
DOI: 10.1016/j.bbcan.2024.189110

A facile synthesis of Cu(II) diethyldithiocarbamate from monovalent copper-cysteamine and disulfiram

Lingyun Wang, Zeliang Chen, Xueguang Ran, Hao Tang and Derong Cao

Inorganic Chemistry Communications, 2022, 137, 109246
DOI: 10.1016/j.inoche.2022.109246

3D‐Bioprinted Mini‐Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics

Marcel Alexander Heinrich, Ruchi Bansal, Twan Lammers, Yu Shrike Zhang, Raymond Michel Schiffelers and Jai Prakash

Advanced Materials, 2019, 31
DOI: 10.1002/adma.201806590

Recent advances in drug delivery systems for targeting brain tumors

Yi Zhao, Ping Yue, Yao Peng, Yuanyuan Sun, Xing Chen, Ze Zhao and Bingjie Han

Drug Delivery, 2023, 30, 1
DOI: 10.1080/10717544.2022.2154409

Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme

Sai Qiao, Ying Cheng, Miao Liu, Qifeng Ji, Bangle Zhang, Qibing Mei, Daozhou Liu and Siyuan Zhou

Journal of Controlled Release, 2021, 336, 54
DOI: 10.1016/j.jconrel.2021.06.015

Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy

Qiaofeng Li, Yu Chao, Bo Liu, Zhisheng Xiao, Zhijuan Yang, Yuzhe Wu and Zhuang Liu

Biomaterials, 2022, 291, 121880
DOI: 10.1016/j.biomaterials.2022.121880

CuET inhibits Ewing sarcoma of bone progression through modulation of the ESM1-MAPK/ERK signaling axis

Wantong Xu, Zhongbiao Jiang and Dan Peng

International Immunopharmacology, 2026, 175, 116444
DOI: 10.1016/j.intimp.2026.116444

Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma

Rishi Sharma, Kevin Liaw, Anjali Sharma, Ambar Jimenez, Michelle Chang, Sebastian Salazar, Imaan Amlani, Sujatha Kannan and Rangaramanujam M. Kannan

Journal of Controlled Release, 2021, 337, 179
DOI: 10.1016/j.jconrel.2021.07.018

Construction of biomimetic nanomedicine delivery system based on biomedical materials for treating brain diseases: A review

Zhihao Chen, Mengru Wu, Xiu Wang and Wanjun Liang

International Journal of Biological Macromolecules, 2026, 350, 151033
DOI: 10.1016/j.ijbiomac.2026.151033

Advancements in dendrimer-based drug delivery for combinatorial cancer therapy

Yaseera Arif, Sameeya, Nazeer Hasan, B.H. Jaswanth Gowda, Garima Gupta, Abdulrhman Alsayari, Shadma Wahab and Prashant Kesharwani

Journal of Drug Delivery Science and Technology, 2024, 97, 105755
DOI: 10.1016/j.jddst.2024.105755

Recent advances in dual-ligand targeted nanocarriers for cancer therapy

Nabab Khan, Ruchika, Rakesh Kumar Dhritlahre and Ankit Saneja

Drug Discovery Today, 2022, 27, 2288
DOI: 10.1016/j.drudis.2022.04.011

Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma

Minjie Wang, Zijie Zhou, Jianglin Zheng, Wenxuan Xiao, Jiameng Zhu, Chaocai Zhang and Xiaobing Jiang

Front. Oncol., 2021, 11
DOI: 10.3389/fonc.2021.650153

Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies

Di Huang, Yinsha Yao, Yifei Lou, Longfa Kou, Qing Yao and Ruijie Chen

International Journal of Pharmaceutics: X, 2024, 8, 100307
DOI: 10.1016/j.ijpx.2024.100307

Detachable Nanoparticle-Enhanced Chemoimmunotherapy Based on Precise Killing of Tumor Seeds and Normalizing the Growing Soil Strategy

Lei Wang, Kaili Ding, Cuixia Zheng, Huifang Xiao, Xinxin Liu, Lingling Sun, Rida Omer, Qianhua Feng and Zhenzhong Zhang

Nano Lett., 2020, 20, 6272
DOI: 10.1021/acs.nanolett.0c01415

Unveiling the role of TAM-derived extracellular vesicles in glioma progression through Treg polarization and immune suppression

Shoudan Zhang, Lin Zhang, Ning Guan, Xu Feng, Miaomiao Lu and Yanyun Wang

Oncogene, 2025, 44, 3364
DOI: 10.1038/s41388-025-03497-8

Novel polysaccharide building hybrid nanoparticles: remodelling TAMs to target ERα-positive breast cancer

Chunjing Guo, Yanguo Su, Bingjie Wang, Qiang Chen, Huimin Guo, Ming Kong and Daquan Chen

Journal of Drug Targeting, 2022, 30, 450
DOI: 10.1080/1061186X.2021.2020798

Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy

Zhongmin Li, Yilun Liu, Xuedong Fang and Zhenbo Shu

IJN, 2021, Volume 16, 1631
DOI: 10.2147/IJN.S290346

The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma

Ji Zhou, Tianyao Guo, Lin Zhou, Meihua Bao, Lin Wang, Wenhu Zhou, Shan Tan, Guangyi Li, Binsheng He and Zhen Guo

Sci Rep, 2023, 13
DOI: 10.1038/s41598-023-28897-2

Hyperbaric Oxygen Boosts Antitumor Efficacy of Copper-Diethyldithiocarbamate Nanoparticles against Pancreatic Ductal Adenocarcinoma by Regulating Cancer Stem Cell Metabolism

Chen Xiao, Jiayuan Li, Ao Hua, Xing Wang, Shiyou Li, Zheng Li, Chen Xu, Zhijie Zhang, Xiangliang Yang and Zifu Li

Research, 2024, 7
DOI: 10.34133/research.0335

Nanomedicine approaches for medulloblastoma therapy

Chaemin Lim, Jain Koo and Kyung Taek Oh

J. Pharm. Investig., 2023, 53, 213
DOI: 10.1007/s40005-022-00597-5

Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment

Baohui Song, Shiyang Wu, Wenpan Li, Dawei Chen and Haiyang Hu

Pharm Res, 2020, 37
DOI: 10.1007/s11095-020-02811-1

Nanomedicine for glioblastoma: Progress and future prospects

Imran Khan, Mohammad Hassan Baig, Sadaf Mahfooz, Mohammad Azhar Imran, Mohd Imran Khan, Jae-June Dong, Jae Yong Cho and Mustafa Aziz Hatiboglu

Seminars in Cancer Biology, 2022, 86, 172
DOI: 10.1016/j.semcancer.2022.06.007

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

Siqi Wu, Qing Tang, Weifeng Fang, Zhe Sun, Meng Zhang, Ergang Liu, Yang Cao and Yongzhuo Huang

Acta Pharmaceutica Sinica B, 2025, 15, 3226
DOI: 10.1016/j.apsb.2025.04.006

Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review

Sara Abdolmaleki, Alireza Aliabadi and Samad Khaksar

J Cancer Res Clin Oncol, 2024, 150
DOI: 10.1007/s00432-024-05641-5

Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

Juan Aparicio-Blanco, Lorena Sanz-Arriazu, Ricardo Lorenzoni and María J. Blanco-Prieto

International Journal of Pharmaceutics, 2020, 581, 119283
DOI: 10.1016/j.ijpharm.2020.119283

Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies

Hong Wang, Yu Zheng, Qiang Sun, Zhen Zhang, Mengnan Zhao, Cheng Peng and Sanjun Shi

J Nanobiotechnol, 2021, 19
DOI: 10.1186/s12951-021-01062-5

Multifunctional nanomedicine strategies to manage brain diseases

Paulo Faria, Catarina Pacheco, Rui Pedro Moura, Bruno Sarmento and Cláudia Martins

Drug Deliv. and Transl. Res., 2023, 13, 1322
DOI: 10.1007/s13346-022-01256-w

Nanomodulation of Macrophages in Multiple Sclerosis

Frances K. Nally, Chiara De Santi and Claire E. McCoy

Cells, 2019, 8, 543
DOI: 10.3390/cells8060543

Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model

Kenta Tsunekuni, Hisato Kawakami, Kazuaki Matsuoka, Hideki Nagase, Seiichiro Mitani and Kazuhiko Nakagawa

JCM, 2020, 9, 4050
DOI: 10.3390/jcm9124050

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma

Lin Tang, Ming Zhang and Chaoyong Liu

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.882257

The brilliance of nanoscience over cancer therapy: Novel promising nanotechnology-based methods for eradicating glioblastoma

Leili Shabani, Milad Abbasi, Masoomeh Amini, Ali Mohammad Amani and Ahmad Vaez

Journal of the Neurological Sciences, 2022, 440, 120316
DOI: 10.1016/j.jns.2022.120316

Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity

Pengfei Zhao, Jiaxin Zhang, Aihua Wu, Meng Zhang, Yuge Zhao, Yisi Tang, Bing Wang, Tianxiang Chen, Feng Li, Qiang Zhao and Yongzhuo Huang

Journal of Controlled Release, 2021, 329, 1249
DOI: 10.1016/j.jconrel.2020.10.052

The interplay of solvent–drug–protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells

Dina O Helal, Mona M A Abdel-Mottaleb, Amany O Kamel, Nadia Rouatbi, Shunping Han, Ahmed-Shawky Geneidi, Khuloud T Al-Jamal and Gehanne A S Awad

Journal of Pharmacy and Pharmacology, 2023, 75, 921
DOI: 10.1093/jpp/rgad020

Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy

Jun Zeng, Yanju Sun, Shuo Sun, Mingxia Jiang, Daijuan Zhang, Wentong Li, Zhijun Liu, Hongcai Shang, Xiuwen Guan and Weifen Zhang

ACS Appl. Mater. Interfaces, 2022, 14, 50475
DOI: 10.1021/acsami.2c11534

A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer

Haizhou Wang, Fei Xu, Meng Zhang, Jing Liu, Fan Wang and Qiu Zhao

DNA and Cell Biology, 2020, 39, 1181
DOI: 10.1089/dna.2020.5490

Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide

Xiaopeng Mo, Zening Zheng, Yang He, Huihai Zhong, Xuejia Kang, Mingjie Shi, Tuanbing Liu, Zheng Jiao and Yongzhuo Huang

Journal of Controlled Release, 2018, 287, 12
DOI: 10.1016/j.jconrel.2018.08.012

The progress and perspective of nanomedicine in modulating the tumor immune microenvironment

Nan Lin, Keqin Tan, Yuhao Wei, Songtao Xie, Jiaming Liu and Xuelei Ma

Acta Pharmaceutica Sinica B, 2026, 16, 137
DOI: 10.1016/j.apsb.2025.10.002

Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy

Prashant Sharma and Mario Otto

Bioactive Materials, 2024, 31, 440
DOI: 10.1016/j.bioactmat.2023.08.022

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma—Old Myth or New Logos?

Francisco Meraz-Torres, Sarah Plöger, Claus Garbe, Heike Niessner and Tobias Sinnberg

Cancers, 2020, 12, 3538
DOI: 10.3390/cancers12123538

Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner

Monika Nehra, U.T. Uthappa, Virendra Kumar, Rajesh Kumar, Chandra Dixit, Neeraj Dilbaghi, Yogendra Kumar Mishra, Sandeep Kumar and Ajeet Kaushik

Journal of Controlled Release, 2021, 338, 224
DOI: 10.1016/j.jconrel.2021.08.027

Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy

Chen Xiao, Jiayuan Li, Xing Wang, Shiyou Li, Chen Xu, Zhijie Zhang, Ao Hua, Ze-yang Ding, Bi-xiang Zhang, Xiangliang Yang and Zifu Li

Journal of Controlled Release, 2023, 356, 288
DOI: 10.1016/j.jconrel.2023.02.043

Precise construction of Regorafenib-loaded gold nanoparticles: investigation of antiproliferative activity and apoptosis induction in liver cancer cells

Meng Yue, Rui Yang, Yakun Jiang and Xiuhua Yang

Journal of Experimental Nanoscience, 2023, 18
DOI: 10.1080/17458080.2023.2254006

GBM immunotherapy: Exploring molecular and clinical frontiers

Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, Sayani Ghosh and Malini Basu

Life Sciences, 2024, 356, 123018
DOI: 10.1016/j.lfs.2024.123018

Update on the development of molecular imaging and nanomedicine in China: Optical imaging

Lina Wu, Hongyan Zou, Hongbin Wang, Sihang Zhang, Shuang Liu, Ying Jiang, Jing Chen, Yingbo Li, Mengping Shao, Ruixin Zhang, Xiaona Li, Jing Dong, Lili Yang, Kai Wang, Xinyuan Zhu and Xilin Sun

WIREs Nanomed Nanobiotechnol, 2021, 13
DOI: 10.1002/wnan.1660

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

Siyuan Chen, Furong Qin, Manni Wang, Yuquan Wei, Zhiyong Qian and Xiawei Wei

Nano Res., 2022, 15, 2177
DOI: 10.1007/s12274-021-3781-5

Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy

Xuejia Kang, Yongzhuo Huang, Huiyuan Wang, Sanika Jadhav, Zongliang Yue, Amit Tiwari and R. Babu

Pharmaceutics, 2023, 16, 61
DOI: 10.3390/pharmaceutics16010061

Dual-modified brain-targeting lipid polymer micelle delivery of anti-miRNA-21 for achieving oral treatment of glioma

Chunpeng Zhang, Xuewen Zhao, Jiahui Zhang, Qian Zhang, Chunmiao Jin, Danlu Li, Xi Chen, Xin Hai, Xin Chen, Xing Tang and Yilei Zhao

Journal of Drug Delivery Science and Technology, 2024, 96, 105721
DOI: 10.1016/j.jddst.2024.105721

Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy

Wenwen Zhao, Zhi Zhang, Mingyuan Xie, Feng Ding, Xiangrong Zheng, Shicheng Sun and Jianyang Du

npj Precis. Onc., 2025, 9
DOI: 10.1038/s41698-025-00920-x

Disulfiram in glioma: Literature review of drug repurposing

Shiyu Zhong, Shengyu Liu, Xin Shi, Xudong Zhang, Kunhang Li, Guojun Liu, Lishuai Li, Shanwei Tao, Bowen Zheng, Weichen Sheng, Ziyin Ye, Qichen Xing, Qingqing Zhai, Lijie Ren, Ying Wu and Yijun Bao

Front. Pharmacol., 2022, 13
DOI: 10.3389/fphar.2022.933655

A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind

Rena Emond, Jeffrey West, Vince K Grolmusz, Patrick A Cosgrove, Aritro Nath, Alexander R A Anderson and Andrea H Bild

Mol Syst Biol, 2026
DOI: 10.1038/s44320-026-00191-z

Design and application of oncolytic viruses for cancer immunotherapy

Erkko Ylösmäki and Vincenzo Cerullo

Current Opinion in Biotechnology, 2020, 65, 25
DOI: 10.1016/j.copbio.2019.11.016

Biomimetic and cell-based nanocarriers – New strategies for brain tumor targeting

D. Mendanha, J. Vieira de Castro, H. Ferreira and N.M. Neves

Journal of Controlled Release, 2021, 337, 482
DOI: 10.1016/j.jconrel.2021.07.047

Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers

Fangqi Jing, Xiaowei Liu, Xiaoxuan Chen, Fanglong Wu and Qinghong Gao

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.1049164

Enzyme-responsive mannose-grafted magnetic nanoparticles for breast and liver cancer therapy and tumor-associated macrophage immunomodulation

Gholam Hossein Darya, Omid Zare, Hamid Reza Karbalaei-Heidari, Sedighe Zeinali, Heather Sheardown and Banafsheh Rastegari

Expert Opinion on Drug Delivery, 2024, 21, 663
DOI: 10.1080/17425247.2024.2347300

Hypocrellin-Based Multifunctional Phototheranostic Agent for NIR-Triggered Targeted Chemo/Photodynamic/Photothermal Synergistic Therapy against Glioblastoma

Chuangli Zhang, Jiasheng Wu, Weimin Liu, Xiuli Zheng, Wenjun Zhang, Chun-Sing Lee and Pengfei Wang

ACS Appl. Bio Mater., 2020, 3, 3817
DOI: 10.1021/acsabm.0c00386

Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents

Yi Gou, GuoJin Huang, Jinlong Li, Feng Yang and Hong Liang

Coordination Chemistry Reviews, 2021, 441, 213975
DOI: 10.1016/j.ccr.2021.213975

Molecular insight of regorafenib treatment for colorectal cancer

Hiroyuki Arai, Francesca Battaglin, Jingyuan Wang, Jae Ho Lo, Shivani Soni, Wu Zhang and Heinz-Josef Lenz

Cancer Treatment Reviews, 2019, 81, 101912
DOI: 10.1016/j.ctrv.2019.101912

Contribution of regulatory T cells to cancer: A review

Masoud Najafi, Bagher Farhood and Keywan Mortezaee

Journal Cellular Physiology, 2019, 234, 7983
DOI: 10.1002/jcp.27553

Nanotherapeutics targeting autophagy regulation for improved cancer therapy

Yunmeng Liu, Yaxin Wang, Jincheng Zhang, Qikai Peng, Xingdong Wang, Xiyue Xiao and Kai Shi

Acta Pharmaceutica Sinica B, 2024, 14, 2447
DOI: 10.1016/j.apsb.2024.03.019

Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy

Ying Zhu, Jianming Liang, Caifang Gao, Anni Wang, Jiaxuan Xia, Chao Hong, Zhirong Zhong, Zhong Zuo, Jisu Kim, Hongwei Ren, Shiyi Li, Qi Wang, Fengxue Zhang and Jianxin Wang

Journal of Controlled Release, 2021, 330, 641
DOI: 10.1016/j.jconrel.2020.12.036

Research progress in tumor targeted immunotherapy

Yuelin Fang, Aihua Yu, Lei Ye and Guangxi Zhai

Expert Opinion on Drug Delivery, 2021, 18, 1067
DOI: 10.1080/17425247.2021.1882992

An update on dual targeting strategy for cancer treatment

Yasamin Davatgaran Taghipour, Amir Zarebkohan, Roya Salehi, Fariborz Rahimi, Vladimir P. Torchilin, Michael R. Hamblin and Alexander Seifalian

Journal of Controlled Release, 2022, 349, 67
DOI: 10.1016/j.jconrel.2022.06.044

Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses

Pilar Calero-Pérez, Shuang Wu, Carles Arús and Ana Candiota

Cancers, 2021, 13, 2663
DOI: 10.3390/cancers13112663

TfR-T12 short peptide and pH sensitive cell transmembrane peptide modified nano-composite micelles for glioma treatment via remodeling tumor microenvironment

Ping Sun, Zherui Wu, Yue Xiao, Han Wu, Qianqian Di, Xibao Zhao, Jiazheng Quan, Haimei Tang, Qingqing Wang and Weilin Chen

Nanomedicine: Nanotechnology, Biology and Medicine, 2022, 41, 102516
DOI: 10.1016/j.nano.2022.102516

Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy

Anna Wróblewska, Agnieszka Szczygieł, Bożena Szermer-Olearnik and Elżbieta Pajtasz-Piasecka

IJN, 2023, Volume 18, 4521
DOI: 10.2147/IJN.S421173

Leveraging the Mononuclear Phagocyte System for Advancing Glioma Theranostics: Current Insights and Future Directions

Wenhui Wang, Ruijing Wen, Qianbei Li, Zhen Cai, Zihao Ou and Lei Zheng

Aggregate, 2025, 6
DOI: 10.1002/agt2.70182

Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy

Chen Qian, Li-Jun Yang and Hong Cui

Front. Pharmacol., 2020, 11
DOI: 10.3389/fphar.2020.00960

Protein based nanomedicine: Promising therapeutic modalities against inflammatory disorders

Yumna Zaheer, Thomas Vorup‐Jensen, Thomas J. Webster, Mukhtiar Ahmed, Waheed S. Khan and Ayesha Ihsan

Nano Select, 2022, 3, 733
DOI: 10.1002/nano.202100214

Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers

Wu Chen, Wen Yang, Pengyu Chen, Yongzhuo Huang and Feng Li

ACS Appl. Mater. Interfaces, 2018, 10, 41118
DOI: 10.1021/acsami.8b14940

Dual and multi-targeted nanoparticles for site-specific brain drug delivery

Yan Luo, Hang Yang, Yi-Fan Zhou and Bo Hu

Journal of Controlled Release, 2020, 317, 195
DOI: 10.1016/j.jconrel.2019.11.037

MAGED4B Promotes Glioma Progression via Inactivation of the TNF-α-induced Apoptotic Pathway by Down-regulating TRIM27 Expression

Can Liu, Jun Liu, Juntang Shao, Cheng Huang, Xingliang Dai, Yujun Shen, Weishu Hou, Yuxian Shen and Yongqiang Yu

Neurosci. Bull., 2023, 39, 273
DOI: 10.1007/s12264-022-00926-6

Controlling Disassembly of Paramagnetic Prodrug and Photosensitizer Nanoassemblies for On-Demand Orthotopic Glioma Theranostics

Ruibing An, Lingjun Liu, Shixuan Wei, Zheng Huang, Ling Qiu, Jianguo Lin, Hong Liu and Deju Ye

ACS Nano, 2022, 16, 20607
DOI: 10.1021/acsnano.2c07491

An Update of Nanoparticle-Based Approaches for Glioblastoma Multiforme Immunotherapy

Lorenzo Taiarol, Beatrice Formicola, Roberta Dal Magro, Silvia Sesana and Francesca Re

Nanomedicine (Lond.), 2020, 15, 1861
DOI: 10.2217/nnm-2020-0132

Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy

Xueqing Sui, Teng Jin, Tonghui Liu, Shiman Wu, Yue Wu, Zhongmin Tang, Yan Ren, Dalong Ni, Zhenwei Yao and Hua Zhang

Front. Chem., 2020, 8
DOI: 10.3389/fchem.2020.00804

Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy

Siqi Chen, Seigmund W. T. Lai, Christine E. Brown and Mingye Feng

Front. Immunol., 2021, 12
DOI: 10.3389/fimmu.2021.635173

Copper-based therapeutic agents for glioma treatment

Huasong Gao, Dan Ding and Luzhong Zhang

Materials Today Chemistry, 2025, 48, 102899
DOI: 10.1016/j.mtchem.2025.102899

High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment

Yixin Tian, Yiquan Ke and Yanxia Ma

PeerJ, 2020, 8, e9038
DOI: 10.7717/peerj.9038

Reprogramming the tumor microenvironment with biotechnology

Minjeong Kim, Na Kyeong Lee, Chi-Pin James Wang, Jaesung Lim, Min Ji Byun, Tae-Hyung Kim, Wooram Park, Dae-Hwan Park, Se-Na Kim and Chun Gwon Park

Biomater Res, 2023, 27
DOI: 10.1186/s40824-023-00343-4

Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway

Yan-Qing Fei, Ru-Ting Shi, Yang-Fan Zhou, Jin-Ze Wu and Zhi Song

Neurochemistry International, 2022, 157, 105348
DOI: 10.1016/j.neuint.2022.105348

Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFRT790M‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery

Weimin Yin, Xiaolu Yu, Xuejia Kang, Yuge Zhao, Pengfei Zhao, Hongyue Jin, Xuhong Fu, Yakun Wan, Chengyuan Peng and Yongzhuo Huang

Small, 2018, 14
DOI: 10.1002/smll.201802372

Albumin-Based Nanotheranostic Probe with Hypoxia Alleviating Potentiates Synchronous Multimodal Imaging and Phototherapy for Glioma

Zhenzhen Yang, Yitian Du, Qi Sun, Yiwei Peng, Rudong Wang, Yu Zhou, Yuqi Wang, Chunli Zhang and Xianrong Qi

ACS Nano, 2020, 14, 6191
DOI: 10.1021/acsnano.0c02249

Anti-alcoholism drug disulfiram for targeting glioma energy metabolism using BBB-penetrating delivery of fixed-dose combination

Pengfei Zhao, Jingkun Qu, Aihua Wu, Shuang Wang, Xueping Tang, Ante Ou, Jiaxin Zhang, Yi Xu, Qiang Zhao and Yongzhuo Huang

Nano Today, 2022, 44, 101448
DOI: 10.1016/j.nantod.2022.101448

PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma

Jinxiang Wang, Nisha Wu, Xiaowei Feng, Yanling Liang, Meijin Huang, Wenle Li, Lingmi Hou and Chengliang Yin

Front. Immunol., 2023, 13
DOI: 10.3389/fimmu.2022.1052692

Biodegradable NIR‐II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor‐Associated Macrophage Reprogramming

Jia Wan, Xianghong Zhang, Dongsheng Tang, Tang Liu and Haihua Xiao

Advanced Materials, 2023, 35
DOI: 10.1002/adma.202209799

Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release

Shaobo Ruan, Yang Zhou, Xinguo Jiang and Huile Gao

Advanced Science, 2021, 8
DOI: 10.1002/advs.202004025

Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth

Xuejia Kang, Qi Wang, Siqi Wu, Chuanyu Wang, Manjusha Annaji, Chung-Hui Huang, Jianzhong Shen, Pengyu Chen and R. Jayachandra Babu

Biomolecules, 2023, 13, 744
DOI: 10.3390/biom13050744

Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

Yang He, Yuefei Fang, Meng Zhang, Yuge Zhao, Bin Tu, Mingjie Shi, Bahtiyor Muhitdinov, Akmal Asrorov, Qin Xu and Yongzhuo Huang

Acta Pharmaceutica Sinica B, 2022, 12, 2057
DOI: 10.1016/j.apsb.2021.09.022

Regorafenib CSF Penetration, Efficacy, and MRI Patterns in Recurrent Malignant Glioma Patients

Pia S. Zeiner, Martina Kinzig, Iris Divé, Gabriele D. Maurer, Katharina Filipski, Patrick N. Harter, Christian Senft, Oliver Bähr, Elke Hattingen, Joachim P. Steinbach, Fritz Sörgel, Martin Voss, Eike Steidl and Michael W. Ronellenfitsch

JCM, 2019, 8, 2031
DOI: 10.3390/jcm8122031

Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery

Zening Zheng, Jiaxin Zhang, Jizong Jiang, Yang He, Wenyuan Zhang, Xiaopeng Mo, Xuejia Kang, Qin Xu, Bing Wang and Yongzhuo Huang

J Immunother Cancer, 2020, 8, e000207
DOI: 10.1136/jitc-2019-000207

Ultrasound‐Activated Piezoelectric Nanoparticles Trigger Microglia Activity Against Glioblastoma Cells

Margherita Montorsi, Carlotta Pucci, Daniele De Pasquale, Attilio Marino, Maria Cristina Ceccarelli, Martina Mazzuferi, Martina Bartolucci, Andrea Petretto, Mirko Prato, Doriana Debellis, Giorgio De Simoni, Giammarino Pugliese, Massimiliano Labardi and Gianni Ciofani

Adv Healthcare Materials, 2024, 13
DOI: 10.1002/adhm.202304331

Cancer stem cell in prostate cancer progression, metastasis and therapy resistance

Poornima Verma, Neha Shukla, Shivani Kumari, M.S. Ansari, Naveen Kumar Gautam and Girijesh Kumar Patel

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023, 1878, 188887
DOI: 10.1016/j.bbcan.2023.188887

Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages

Yun Zhang, Yalan Chen, Jiahao Li, Xueqin Zhu, Yajing Liu, Xiaoxi Wang, Hongfei Wang, Yongjie Yao, Yanfeng Gao and Zhenzhen Chen

ACS Appl. Mater. Interfaces, 2021, 13, 24442
DOI: 10.1021/acsami.1c01453

Reprogramming Tumor Associated Macrophages toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy

Xiaoxuan Xu, Xiang Gong, Yuqi Wang, Jie Li, Hong Wang, Jiaoying Wang, Xianyi Sha, Yaping Li and Zhiwen Zhang

Advanced Therapeutics, 2020, 3
DOI: 10.1002/adtp.201900181

Nanoparticles as immunomodulators and translational agents in brain tumors

Adam J. Grippin, Kyle A. Dyson, Sadeem Qdaisat, James McGuiness, Brandon Wummer, Duane A. Mitchell, Hector R. Mendez-Gomez and Elias J. Sayour

J Neurooncol, 2021, 151, 29
DOI: 10.1007/s11060-020-03559-9

Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives

Xiande Wang, Cheng Wu, Shiming Liu and Deqing Peng

Drug Delivery, 2022, 29, 1370
DOI: 10.1080/10717544.2022.2069881

Mono- and Dimeric Xanthones with Anti-Glioma and Anti-Inflammatory Activities from the Ascidian-Derived Fungus Diaporthe sp. SYSU-MS4722

Senhua Chen, Heng Guo, Minghua Jiang, Qilin Wu, Jing Li, Hongjie Shen and Lan Liu

Marine Drugs, 2022, 20, 51
DOI: 10.3390/md20010051

Extracellular matrix and its therapeutic potential for cancer treatment

Jiacheng Huang, Lele Zhang, Dalong Wan, Lin Zhou, Shusen Zheng, Shengzhang Lin and Yiting Qiao

Sig Transduct Target Ther, 2021, 6
DOI: 10.1038/s41392-021-00544-0

Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review

Beáta-Mária Benkő, Dimitrios A. Lamprou, Anna Sebestyén, Romána Zelkó and István Sebe

Expert Opinion on Drug Delivery, 2023, 20, 541
DOI: 10.1080/17425247.2023.2190581

Polysaccharide Adjuvants as Innate Immune Trainers: Bridging Pattern Recognition Receptor (PRR) Activation and Metabolic Reprogramming for Synthetic Vaccine Design

Jeong Hyun Moon, May Thazin Phoo, Yubin Kim, Jinsung Ahn, April Kim, Jutaek Nam, Soo‐Hong Lee, James J. Moon and Sejin Son

Advanced Science, 2025, 12
DOI: 10.1002/advs.202509022

Matrix Stiffness and Colorectal Cancer

Chongshun Liu, Haiping Pei and Fengbo Tan

OTT, 2020, Volume 13, 2747
DOI: 10.2147/OTT.S231010

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

Muhammad Usman Akbar, Weiwei Guo, Xin Shen, Yimeng Fang, Yilin Liu, Peng‐Yuan Wang, Roey Elnathan and Yaping Chen

Advanced Therapeutics, 2025, 8
DOI: 10.1002/adtp.202500124

Cancer‐associated fibroblasts: Secretions, interactions, and therapy

Bagher Farhood, Masoud Najafi and Keywan Mortezaee

J of Cellular Biochemistry, 2019, 120, 2791
DOI: 10.1002/jcb.27703

Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma

Li Qiao, Huishu Yang, Xin-xin Shao, Qiuyan Yin, Xian-Jun Fu and Qingcong Wei

Mol. Pharmaceutics, 2022, 19, 1927
DOI: 10.1021/acs.molpharmaceut.1c00856

Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma

Francisco Branco, Joana Cunha, Maria Mendes, Carla Vitorino and João J. Sousa

ACS Nano, 2024, 18, 16359
DOI: 10.1021/acsnano.4c01790

A pH transformable nanocarrier for gradual and precise delivery of a natural immunomodulator and chemotherapy agent to trigger tumor apoptosis

Qianwen Sun, Wei Chen, Qi Zhang, Yanqi Han, Yue Gao, Jun Ye, Hongliang Wang, Yi Zhang, Lili Gao, Yuling Liu and Yanfang Yang

Chemical Engineering Journal, 2024, 495, 153209
DOI: 10.1016/j.cej.2024.153209

Specifically Eliminating Tumor-Associated Macrophages with an Extra- and Intracellular Stepwise-Responsive Nanocarrier for Inhibiting Metastasis

Ningning Guo, Yi Zhou, Tiantian Wang, Mengting Lin, Jiejian Chen, Zhentao Zhang, Xincheng Zhong, Yiying Lu, Qiyao Yang, Donghang Xu, Jianqing Gao and Min Han

ACS Appl. Mater. Interfaces, 2020, 12, 57798
DOI: 10.1021/acsami.0c19301

Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives

Minfeng Yang, In Young Oh, Arpan Mahanty, Wei-Lin Jin and Jung Sun Yoo

Cancers, 2020, 12, 2334
DOI: 10.3390/cancers12092334

Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation

Qin Guo, Xi He, Chao Li, Yongqing He, Yiying Peng, Yu Zhang, Yifei Lu, Xinli Chen, Yujie Zhang, Qinjun Chen, Tao Sun and Chen Jiang

Advanced Science, 2019, 6
DOI: 10.1002/advs.201901430

Oncolytic Adenoviruses for Cancer Therapy

Lorella Tripodi, Maria Vitale, Vincenzo Cerullo and Lucio Pastore

IJMS, 2021, 22, 2517
DOI: 10.3390/ijms22052517

Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer

Ya Chang, Jizong Jiang, Wu Chen, Wen Yang, Lili Chen, Pengyu Chen, Jianzhong Shen, Shizhi Qian, Teng Zhou, Linfeng Wu, Liang Hong, Yongzhuo Huang and Feng Li

Applied Materials Today, 2020, 18, 100492
DOI: 10.1016/j.apmt.2019.100492

Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens

Yao Lu, Qingqing Pan, Wenxia Gao, Yuji Pu, Kui Luo, Bin He and Zhongwei Gu

Biomaterials, 2022, 281, 121335
DOI: 10.1016/j.biomaterials.2021.121335

Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1

Hairui Wang, Yisi Tang, Yuefei Fang, Meng Zhang, Huiyuan Wang, Zhidi He, Bing Wang, Qin Xu and Yongzhuo Huang

Nano Lett., 2019, 19, 2935
DOI: 10.1021/acs.nanolett.9b00021

Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas

Qing Zhang and Fusheng Liu

Cell Death Dis, 2020, 11
DOI: 10.1038/s41419-020-2696-5

Cancer stem cell (CSC) resistance drivers

Masoud Najafi, Keywan Mortezaee and Jamal Majidpoor

Life Sciences, 2019, 234, 116781
DOI: 10.1016/j.lfs.2019.116781

A natural protein based platform for the delivery of Temozolomide acid to glioma cells

Dina O. Helal, Nadia Rouatbi, Shunping Han, Julie Tzu-Wen Wang, Adam A. Walters, Mona M.A. Abdel-Mottaleb, Amany O. Kamel, Ahmed-Shawky Geneidi, Gehanne A.S. Awad and Khuloud T. Al-Jamal

European Journal of Pharmaceutics and Biopharmaceutics, 2021, 169, 297
DOI: 10.1016/j.ejpb.2021.10.007

Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer

Bingjie Wang, Wei Zhang, Xiudi Zhou, Mengna Liu, Xiaoya Hou, Ziting Cheng and Daquan Chen

Drug Delivery, 2019, 26, 1265
DOI: 10.1080/10717544.2019.1693707

Functional T cell activation by smart nanosystems for effective cancer immunotherapy

Weijing Yang, Zijian Zhou, Joseph Lau, Shuo Hu and Xiaoyuan Chen

Nano Today, 2019, 27, 28
DOI: 10.1016/j.nantod.2019.05.004

Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects

Jun Chen and Xiufeng Cong

Biomedicine & Pharmacotherapy, 2023, 157, 113998
DOI: 10.1016/j.biopha.2022.113998

Strategies of designing lymph nodes-targeting nanoparticles for cancer immunotherapy

Zhiyuan Huang, Fangqiu Fu, Chaoqiang Deng, Shiyang Wu, Mingxuan Huang, Xianyi Sha, Ming Q Wei, Zhiwen Zhang and Yang Zhang

Chinese Chemical Letters, 2025, 111993
DOI: 10.1016/j.cclet.2025.111993

Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation

Guorong Hu, Mengfei Guo, Juanjuan Xu, Feng Wu, Jinshuo Fan, Qi Huang, Guanghai Yang, Zhilei Lv, Xuan Wang and Yang Jin

Front. Immunol., 2019, 10
DOI: 10.3389/fimmu.2019.01998

Albumin-based nanocarriers: Singularities, synthesis methods, clinical relevance and targeting strategies in cancer

Edgar Pérez-Herrero, Alberto Fernández-Medarde and Juan M. Irache

Acta Pharmaceutica Sinica B, 2026, 16, 1883
DOI: 10.1016/j.apsb.2025.11.035

Tumor‐associated macrophages as treatment targets in glioma

Yichen Peng, Feng Chen, Shenglan Li, Xiu Liu, Can Wang, Chunna Yu and Wenbin Li

Brain Science Advances, 2020, 6, 306
DOI: 10.26599/BSA.2020.9050015

Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy

Jianming Liang, Ying Zhu, Caifang Gao, Chengli Ling, Jing Qin, Qi Wang, Yongzhuo Huang, Weigen Lu and Jianxin Wang

NPG Asia Mater, 2019, 11
DOI: 10.1038/s41427-019-0138-6

Nanoparticles target M2 macrophages to silence kallikrein-related peptidase 12 for the treatment of tuberculosis and drug-resistant tuberculosis

Yuanzhi Wang, Yiduo Liu, Meizhen Long, Yuhui Dong, Lin Li and Xiangmei Zhou

Acta Biomaterialia, 2024, 188, 358
DOI: 10.1016/j.actbio.2024.09.026

Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy

Rana Shafabakhsh, Mohammad Hossein Pourhanifeh, Hamid Reza Mirzaei, Amirhossein Sahebkar, Zatollah Asemi and Hamed Mirzaei

Pharmacological Research, 2019, 147, 104353
DOI: 10.1016/j.phrs.2019.104353

Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy

Rui Wang, Wenqin Song, Jie Zhu, Xinyue Shao, Chenxiao Yang, Wei Xiong, Bing Wang, Pengfei Zhao, Meiwan Chen and Yongzhuo Huang

Journal of Controlled Release, 2024, 368, 84
DOI: 10.1016/j.jconrel.2024.02.004

SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma

Xinqi Ge, Ziheng Wang, Rui Jiang, Shiqi Ren, Wei Wang, Bing Wu, Yu Zhang and Qianqian Liu

The International Journal of Biochemistry & Cell Biology, 2021, 139, 106054
DOI: 10.1016/j.biocel.2021.106054

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

Hao Lin, Chaxian Liu, Ankang Hu, Duanwu Zhang, Hui Yang and Ying Mao

J Hematol Oncol, 2024, 17
DOI: 10.1186/s13045-024-01544-7

Complete Response to the Sequential Treatment with Regorafenib Followed by PD-1 Inhibitor in a Sorafenib-Refractory Hepatocellular Carcinoma Patient

Er-lei Zhang, Zun-yi Zhang, Jian Li and Zhi-yong Huang

OTT, 2020, Volume 13, 12477
DOI: 10.2147/OTT.S284092

Gather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas

Jiwei Cui, Yuanxin Xu, Haiyan Tu, Huacong Zhao, Honglan Wang, Liuqing Di and Ruoning Wang

Acta Pharmaceutica Sinica B, 2022, 12, 1100
DOI: 10.1016/j.apsb.2021.08.013

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

Bagher Farhood, Masoud Najafi and Keywan Mortezaee

Journal Cellular Physiology, 2019, 234, 8509
DOI: 10.1002/jcp.27782

Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma

Jia-yu Cai, Yang Liu, Lu Zhang, Rui-bo Guo, Yang Liu, Xue-tao Li, Ling-yue Ma and Liang Kong

Journal of Drug Delivery Science and Technology, 2024, 93, 105387
DOI: 10.1016/j.jddst.2024.105387

How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature

Yongqing Yang, Nianlan Cheng, Qiao Luo, Ni Shao, Xiaocong Ma, Jifeng Chen, Liangping Luo and Zeyu Xiao

IJN, 2023, Volume 18, 3663
DOI: 10.2147/IJN.S414736

Nanotechnology-Based Combinatorial Anti-Glioblastoma Therapies: Moving from Terminal to Treatable

Amir Barzegar Behrooz, Zahra Talaie and Amir Syahir

Pharmaceutics, 2022, 14, 1697
DOI: 10.3390/pharmaceutics14081697

Apoferritin as a Carrier of Cu(II) Diethyldithiocarbamate and Biomedical Application for Glutathione-Responsive Combination Chemotherapy

Xiao Li, Ke Du, Jian Sun and Fude Feng

ACS Appl. Bio Mater., 2020, 3, 654
DOI: 10.1021/acsabm.9b01014

Targeting Tumor Microenvironment-associated Immune Cells with Nanoparticles-based Strategies

Najla Suhail Alotaibi

Pharmacophore, 2021, 12, 1
DOI: 10.51847/PJ1xCWaW3U

The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics

Sijia Zhang, Yan Zong, Leichong Chen, Qianwen Li, Zhenyu Li and Rui Meng

Discov Onc, 2023, 14
DOI: 10.1007/s12672-023-00729-9

Turning adversity into opportunity: Small extracellular vesicles as nanocarriers for tumor‐associated macrophages re‐education

Dario Donoso‐Meneses, Aliosha I. Figueroa‐Valdés, Nicolás Georges, Hugo E. Tobar and Francisca Alcayaga‐Miranda

Bioengineering & Transla Med, 2023, 8
DOI: 10.1002/btm2.10349